Common characteristics of HIV-1 infection such as establishment of latently infected reservoirs, impracticality of therapy delivery to anatomically privileged sites, and the ongoing development of drug resistant viruses continue to challenge efficacies of CCR5 targeting strategies (178). This evidence concerns the gene CCR5 and HIV-1 infection.